Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FCFDA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,618
Award facts
- Contract value 100% obligated
- $27,617.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $27,617.57 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on September 15, 2025, with completion targeted for September 16, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Cosentyx, a specialty biologic immunosuppressant medication, represents the type of specialized pharmaceutical commodity that DLA procures through this contract vehicle to support Defense Health Agency operations and other government healthcare systems. AmerisourceBergen's status as a prime vendor under the DLA Troop Support Medical contract reflects the company's demonstrated capability to fulfill federal procurement requirements through competitive procurement processes and manage complex pharmaceutical supply chains serving military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FCFDA?
SPE2DB25FCFDA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FCFDA worth?
The government has obligated $27,618 on SPE2DB25FCFDA.
Is contract SPE2DB25FCFDA an order under another contract?
Yes. SPE2DB25FCFDA is a delivery order under SPE2DB24D1006, an indefinite delivery contract.
Was contract SPE2DB25FCFDA competed?
The extent of competition for SPE2DB25FCFDA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award